N. SOYER Et Al. , "Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.3, pp.1033-1042, 2021
SOYER, N. Et Al. 2021. Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.3 , 1033-1042.
SOYER, N., ALİ, R., Turgut, M., HAZNEDAROĞLU, İ. C., Yilmaz, F., AYDOĞDU, İ., ... PİR, A.(2021). Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.3, 1033-1042.
SOYER, NUR Et Al. "Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.3, 1033-1042, 2021
SOYER, NUR Et Al. "Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.3, pp.1033-1042, 2021
SOYER, N. Et Al. (2021) . "Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.3, pp.1033-1042.
@article{article, author={NUR SOYER Et Al. }, title={Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2021, pages={1033-1042} }